Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Exo1 是一种胞吐途径的化学抑制剂。
产品描述 | Exo1 is an inhibitor of the exocytic pathway |
体外活性 | Exo1 is a modifier of Golgi ARF1 GTPase activity. It provides an independent means to interfere with Golgi activity, because Exo1 affects a subset of the membrane events that are blocked by BFA, but seems to have a different protein target (and presumably has different side effects). Exo1 Disrupts Vesicular Traffic from the ER to the Golgi apparatus by disrupting Golgi structures. Exo1 inhibits exocytosis with an IC50 of ~20 μM. Exo1 prevents acquisition of endoglycosidase H resistance by newly synthesized proteins such as VSVGts-GFP, transferrin, and MHC class I[1] . |
分子量 | 273.26 |
分子式 | C15H12FNO3 |
CAS No. | 75541-83-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 22.5 mg/mL (82.34 mM)
( < 1 mg/mL refers to the product slightly soluble or insoluble )
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
bottom
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Exo1 75541-83-2 Others inhibit Exo-1 Exo 1 Inhibitor inhibitor